| Site-specific bioconjugation approaches for enhanced delivery of protein therapeutics and protein drug carriers RM Lieser, D Yur, MO Sullivan, W Chen Bioconjugate chemistry 31 (10), 2272-2282, 2020 | 51 | 2020 |
| Modular hepatitis B virus-like particle platform for biosensing and drug delivery EJ Hartzell, RM Lieser, MO Sullivan, W Chen Acs Nano 14 (10), 12642-12651, 2020 | 51 | 2020 |
| Controlled epidermal growth factor receptor ligand display on cancer suicide enzymes via unnatural amino acid engineering for enhanced intracellular delivery in breast cancer cells RM Lieser, W Chen, MO Sullivan Bioconjugate Chemistry 30 (2), 432-442, 2019 | 29 | 2019 |
| Incorporation of endosomolytic peptides with varying disruption mechanisms into EGFR-Targeted protein conjugates: the effect on intracellular protein delivery and EGFR … RM Lieser, Q Li, W Chen, MO Sullivan Molecular Pharmaceutics 19 (2), 661-673, 2022 | 16 | 2022 |
| Engineering bionanoparticles for improved biosensing and bioimaging D Yur, RM Lieser, MO Sullivan, W Chen Current Opinion in Biotechnology 71, 41-48, 2021 | 16 | 2021 |
| EGFR ligand clustering on E2 bionanoparticles for targeted delivery of chemotherapeutics to breast cancer cells RM Lieser, EJ Hartzell, D Yur, MO Sullivan, W Chen Bioconjugate Chemistry 33 (3), 452-462, 2022 | 14 | 2022 |
| Addressing intracellular protein delivery challenges with site-specific protein conjugation strategies for breast cancer treatment RM Lieser University of Delaware, 2021 | | 2021 |
| Controlled EGFR ligand display on cancer suicide enzymes for targeted intracellular delivery R Lieser, M Sullivan, W Chen ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
| Controlled EGFR ligand display for tunable targeted intracellular delivery of cancer suicide enzymes R Lieser, W Chen, M Sullivan | | 2018 |
